| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.UROLOGY.2014.05.009 |
| P698 | PubMed publication ID | 24975710 |
| P50 | author | Brandon A Mahal | Q85643167 |
| Marianne Schmid | Q87169715 | ||
| Toni K Choueiri | Q88414622 | ||
| Anthony V D'Amico | Q114316626 | ||
| P2093 | author name string | Paul L Nguyen | |
| Jesse D Sammon | |||
| Quoc-Dien Trinh | |||
| Simon P Kim | |||
| Christopher J Sweeney | |||
| Clair J Beard | |||
| Jim C Hu | |||
| Ayal A Aizer | |||
| Andrew S Hyatt | |||
| Neil E Martin | |||
| David R Ziehr | |||
| P2860 | cites work | Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study. | Q50851269 |
| Radiotherapy and short-term androgen deprivation for localized prostate cancer. | Q51021354 | ||
| Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 | ||
| Radical prostatectomy versus watchful waiting in early prostate cancer | Q57137210 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Association of insurance with cancer care utilization and outcomes | Q28261934 | ||
| Patient preference and contraindications in measuring quality of care: what do administrative data miss? | Q30644505 | ||
| Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial | Q35627417 | ||
| Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer | Q35888084 | ||
| A new approach to understanding racial disparities in prostate cancer treatment | Q36971869 | ||
| African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? | Q37085854 | ||
| Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina. | Q37178150 | ||
| Racial differences in medical mistrust among men diagnosed with prostate cancer | Q37239230 | ||
| Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance | Q37689278 | ||
| Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison | Q38056217 | ||
| Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial | Q42606697 | ||
| Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial | Q42644117 | ||
| Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial | Q46482531 | ||
| Explaining racial differences in prostate cancer mortality | Q46526838 | ||
| Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. | Q46733585 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 386-392 | |
| P577 | publication date | 2014-06-26 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups | |
| P478 | volume | 84 |
| Q40584866 | A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer |
| Q39673134 | Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort |
| Q59478489 | Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer |
| Q42378371 | Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study. |
| Q91267187 | Factors influencing prostate cancer treatment decisions for African American and white men |
| Q40476413 | Geographical Factors Associated With Health Disparities in Prostate Cancer. |
| Q53708209 | Impact of individual and neighborhood factors on disparities in prostate cancer survival. |
| Q92803874 | Looking at cancer health disparities without the colored lenses |
| Q51759873 | Marital status and head and neck cancer outcomes. |
| Q39585300 | National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers? |
| Q40561515 | Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients |
| Q38683379 | Prostate cancer in men of African origin. |
| Q48102221 | Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance. |
| Q39611918 | Racial Disparities Differ for African Americans and Hispanics in the Diagnosis and Treatment of Penile Cancer |
| Q90108136 | Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA |
| Q65001466 | Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation. |
| Q41147765 | Racial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer. |
| Q92297099 | Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials |
| Q48194820 | Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer |
| Q91898634 | Tailoring survivorship to diverse populations with genitourinary malignancies |
| Q88307950 | The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality After Radical Prostatectomy in Hispanic or Latino Men: A Population-based Analysis |
| Q104289443 | The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer |
| Q46084626 | Travel distance and stereotactic body radiotherapy for localized prostate cancer |
| Q33591357 | Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification |
Search more.